Insmed (INSM) Other Accumulated Expenses (2011 - 2026)

Insmed has reported Other Accumulated Expenses for 16 years, with the latest figure at $37.8 million in Q2 2026.

• On a quarterly basis, Other Accumulated Expenses rose 362.8% year-over-year to $37.8 million in Q2 2026; TTM through Jun 2026 was $37.8 million, a 362.8% increase from a year earlier, with the FY2025 full-year figure at $17.1 million, up 170.41% from the prior year.
• Other Accumulated Expenses was $37.8 million for Q2 2026 at Insmed, up from $23.3 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $37.8 million in Q2 2026, with the low at $4.7 million in Q4 2022.
• Average Other Accumulated Expenses over 5 years is $10.9 million, with a median of $8.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Other Accumulated Expenses dropped 29.23% in 2022, then surged 362.8% in 2026.
• Over 5 years, Other Accumulated Expenses stood at $4.7 million in 2022, then advanced by 20.47% to $5.7 million in 2023, then advanced by 11.46% to $6.3 million in 2024, then surged by 170.41% to $17.1 million in 2025, then surged by 120.89% to $37.8 million in 2026.
• The last three Other Accumulated Expenses figures came in at $37.8 million (Q2 2026), $23.3 million (Q1 2026), and $17.1 million (Q4 2025), per Business Quant data.